Multicenter Randomized Trial of 10-French versus 11.5-French Plastic Stents for Malignant Biliary Obstruction

Table 2

Outcomes in patients stented with 10 Fr and 11.5 Fr stents.

	10 Fr (𝑛=115)	11.5 Fr (𝑛=119)	𝑃 value
Technical success	99.1% (114/115)	97.4% (116/119)	0.37
Baseline bilirubin (mg/dL)	10.7 ± 6.8	12.8 ± 7.6	0.03
Bilirubin decrease (mg/dL)	8.7 ± 6.1*	10.6 ± 6.9*	0.077*
Days to stent failure	149	258	0.16
Stent-related hosp. days (Mean)	1.6 ± 3.5	1.9 ± 3.8	0.50
Stent-related interventions (mean)	0.74 ± 1.5	0.82 ± 1.5	0.66
Median patient survival days	151	206	0.20

∗After adjusting for difference in baseline bilirubin.